Lorbrena 00069-0231

Generic: Lorlatinib

Product NDC

00069-0231

Manufacturer: Pfizer Laboratories Div Pfizer Inc
Dosage Form: Tablet, Film Coated
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: November 19, 2018
Listing Expires: December 31, 2027
Application: NDA210868

Need to source Lorbrena? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lorlatinib	100 mg/1

Drug Class

Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2B6 Inducers [MoA]

Packaging Options(1)

00069-0231-01

30 TABLET, FILM COATED in 1 BOTTLE (0069-0231-01)

View →